Litcius/Paper detail

β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease

Ignatios Ikonomidis, Κ Katogiannis, Elias Kyriakou, Maria Taichert, Georgios Katsimaglis, Maria Tsoumani, Ioanna Andreadou, Eirini Maratou, Vaia Lambadiari, Foteini Kousathana, Anna Papadopoulou, Charalampos Varlamos, Panagiotis Plotas, John Parissis, Κimon Stamatelopoulos, Dimitrios Alexopoulos, George Dimitriadis, Argirios Ε. Tsantes

2020Journal of Thrombosis and Thrombolysis15 citationsDOI

Topics & Concepts

MedicineInternal medicineHematologyCoronary artery diseaseCardiologyPlateletAdverse effectDiseasePlatelet aggregationGDF15 and Related BiomarkersInflammation biomarkers and pathwaysAdipokines, Inflammation, and Metabolic Diseases
β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease | Litcius